AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

1
Player Avatar kcanant (99.88) Submitted: 2/4/2009 2:46:41 PM : Outperform Start Price: $32.15 AZN Score: -33.14

Re-load. Div yield 5.1% P/E 16

Featured Broker Partners


Advertisement